(Q43493525)

English

T-helper cell-mediated interferon-gamma, interleukin-10 and proliferation responses to a candidate recombinant vaccine for human parvovirus B19.

scientific article published in September 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

24 November 2017

T-helper cell-mediated interferon-gamma, interleukin-10 and proliferation responses to a candidate recombinant vaccine for human parvovirus B19. (English)

1 reference

Europe PubMed Central

24 November 2017

author name string

Rauli Franssila

1

1 reference

Europe PubMed Central

24 November 2017

Klaus Hedman

2

1 reference

Europe PubMed Central

24 November 2017

language of work or name

0 references

publication date

1 September 2004

1 reference

Europe PubMed Central

24 November 2017

1 reference

Europe PubMed Central

24 November 2017

22

1 reference

Europe PubMed Central

24 November 2017

27-28

1 reference

Europe PubMed Central

24 November 2017

3809-3815

1 reference

Europe PubMed Central

24 November 2017

Candidate recombinant vaccine for human B19 parvovirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.06.003

7 January 2021

Unique region of the minor capsid protein of human parvovirus B19 is exposed on the virion surface

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.06.003

7 January 2021

An outbreak of erythema infectiosum associated with human parvovirus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.06.003

7 January 2021

HUMAN PARVOVIRUS ARTHROPATHY

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.06.003

7 January 2021

Immune response to B19 parvovirus and an antibody defect in persistent viral infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.06.003

7 January 2021

Chronic parvovirus infection in a presumably immunologically healthy woman

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.06.003

7 January 2021

Persistence of parvovirus B19 DNA in synovial membranes of young patients with and without chronic arthropathy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.06.003

7 January 2021

Frequency of human parvovirus B19 infection in intrauterine fetal death

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.06.003

7 January 2021

Molecular, cellular and clinical aspects of parvovirus B19 infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.06.003

7 January 2021

Generation of neutralizing anti-B19 parvovirus human monoclonal antibodies from patients infected with human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.06.003

7 January 2021

Epitope type-specific IgG responses to capsid proteins VP1 and VP2 of human parvovirus B19.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.06.003

7 January 2021

Self-assembled B19 parvovirus capsids, produced in a baculovirus system, are antigenically and immunogenically similar to native virions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.06.003

7 January 2021

Induction of immunoglobulin synthesis by CD4+ T cell clones

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.06.003

7 January 2021

Persistence of memory B cells in mice deprived of T cell help.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.06.003

7 January 2021

The CD40 antigen and its ligand

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.06.003

7 January 2021

Helper activity for immunoglobulin synthesis of T helper type 1 (Th1) and Th2 human T cell clones: the help of Th1 clones is limited by their cytolytic capacity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.06.003

7 January 2021

T helper cell-mediated in vitro responses of recently and remotely infected subjects to a candidate recombinant vaccine for human parvovirus b19

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.06.003

7 January 2021

The molecular cell biology of interferon-gamma and its receptor

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.06.003

7 January 2021

IgG subclass response to human parvovirus B19 infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.06.003

7 January 2021

Impaired gamma interferon responses against parvovirus B19 by recently infected children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.06.003

7 January 2021

Human interleukin 10 induces naive surface immunoglobulin D+ (sIgD+) B cells to secrete IgG1 and IgG3

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.06.003

7 January 2021

Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.06.003

7 January 2021

Long-term cultured CD40-activated B lymphocytes differentiate into plasma cells in response to IL-10 but not IL-4.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.06.003

7 January 2021

Direct ex vivo measurement of CD8(+) T-lymphocyte responses to human parvovirus B19.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.06.003

7 January 2021

Lymphocyte recognition of human parvovirus B19 non-structural (NS1) protein: associations with occurrence of acute and chronic arthropathy?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.06.003

7 January 2021

Modulation of antigen processing by bound antibodies can boost or suppress class II major histocompatibility complex presentation of different T cell determinants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.06.003

7 January 2021

Generation of neutralizing human monoclonal antibodies against parvovirus B19 proteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.06.003

7 January 2021

Acute-phase-specific heptapeptide epitope for diagnosis of parvovirus B19 infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.06.003

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2003.06.003

1 reference

Europe PubMed Central

24 November 2017

1 reference

Europe PubMed Central

24 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43493525&oldid=1612944774"